HK11489A - Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound - Google Patents

Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound

Info

Publication number
HK11489A
HK11489A HK114/89A HK11489A HK11489A HK 11489 A HK11489 A HK 11489A HK 114/89 A HK114/89 A HK 114/89A HK 11489 A HK11489 A HK 11489A HK 11489 A HK11489 A HK 11489A
Authority
HK
Hong Kong
Prior art keywords
tetrahydro
dihydroxy
hydroxyphenyl
beta
adrenergic blocking
Prior art date
Application number
HK114/89A
Other languages
English (en)
Inventor
Dennis Marvin Ackerman
Barry Alan Berkowitz
Virgil Daniel Wiebelhaus
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of HK11489A publication Critical patent/HK11489A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
HK114/89A 1981-12-08 1989-02-09 Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound HK11489A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP81110252A EP0081006B1 (en) 1981-12-08 1981-12-08 Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound

Publications (1)

Publication Number Publication Date
HK11489A true HK11489A (en) 1989-02-17

Family

ID=8188060

Family Applications (1)

Application Number Title Priority Date Filing Date
HK114/89A HK11489A (en) 1981-12-08 1989-02-09 Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound

Country Status (18)

Country Link
US (1) US4469690A (pt)
EP (1) EP0081006B1 (pt)
JP (1) JPS58105921A (pt)
AT (1) ATE15762T1 (pt)
AU (1) AU550892B2 (pt)
CA (1) CA1183777A (pt)
DE (1) DE3172458D1 (pt)
GR (1) GR77842B (pt)
HK (1) HK11489A (pt)
HU (1) HU187804B (pt)
IL (1) IL67310A (pt)
MY (1) MY8700934A (pt)
NZ (1) NZ202510A (pt)
PH (1) PH22073A (pt)
PT (1) PT75915B (pt)
SG (1) SG61188G (pt)
ZA (1) ZA829004B (pt)
ZW (1) ZW25482A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0365134A1 (en) * 1988-09-16 1990-04-25 Smithkline Beecham Corporation Synergistic compositions of renal dopaminergic agent and angiotensin converting enzyme inhibitors
EP0476156B1 (en) * 1990-04-06 1996-08-07 Eisai Co., Ltd. Solid oral preparation containing catechol compound
EP1079859B1 (en) 1998-05-22 2010-07-14 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US7022342B2 (en) 2002-03-28 2006-04-04 Andrx Corporation, Inc. Controlled release oral dosage form of beta-adrenergic blocking agents
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011319A (en) * 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives
DE2638716A1 (de) * 1976-08-27 1978-03-02 Ici Gmbh Antihypertensiva
US4160765A (en) * 1976-11-17 1979-07-10 Smithkline Corporation Method for 6-bromination of 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
US4171359A (en) * 1978-04-12 1979-10-16 Smithkline Corporation Benz-tetrasubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4265889A (en) * 1978-05-05 1981-05-05 Smithkline Corporation 6-Lower alkyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4192297A (en) * 1978-05-25 1980-03-11 Leopold Labrecque Therapeutic feet bathing device
DE2850078A1 (de) * 1978-11-18 1980-05-29 Basf Ag Aminopropanolderivate des 6-hydroxy-2,3,4,5-tetrahydro-1h-1- benzazepin-2-ons
DE3065940D1 (en) * 1979-07-10 1984-01-26 Smithkline Beckman Corp Synergistic antihypertensive compositions

Also Published As

Publication number Publication date
DE3172458D1 (en) 1985-10-31
MY8700934A (en) 1987-12-31
AU550892B2 (en) 1986-04-10
ZW25482A1 (en) 1983-02-23
JPS58105921A (ja) 1983-06-24
US4469690A (en) 1984-09-04
NZ202510A (en) 1985-09-13
GR77842B (pt) 1984-09-25
EP0081006B1 (en) 1985-09-25
HU187804B (en) 1986-02-28
EP0081006A1 (en) 1983-06-15
PH22073A (en) 1988-05-20
SG61188G (en) 1989-07-07
CA1183777A (en) 1985-03-12
AU9084482A (en) 1983-06-16
IL67310A (en) 1988-09-30
ATE15762T1 (de) 1985-10-15
PT75915A (en) 1982-12-01
PT75915B (en) 1985-11-15
ZA829004B (en) 1983-09-28

Similar Documents

Publication Publication Date Title
OA08481A (fr) Dérivés d'indolizine, leur procédé de préparation ainsi que les compositions les contenant.
BR9100016A (pt) Composto,isotopo radioativo do mesmo,composicao farmaceutica,metodo de tratamento ou prevencao de estados de mamiferos
NO821586L (no) Fremgangsmaate til fremstilling av 1,2-diamino-cyklobuten-3,4-dioner.
DE3172458D1 (en) Pharmaceutical compositions comprising 7,8-dihydroxy-1(hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-benzazepine derivatives and a beta-adrenergic blocking compound
OA09441A (fr) "Procédés de préparation de ptéridin-4(3H)-ones, et de compositions médicamenteuses les contenant".
OA07525A (fr) Dérivés d'acides-animés, leur préparation et utilisation ainsi que les compositions contenant ces dérivés.
ES513672A0 (es) "procedimiento para la preparacion de derivados de penem".
IL72188A (en) 7-piperidino-1,2,3,5-tetrahydroimidazo(2,1-b)-quinazolin-2-one and salts thereof,their preparation and pharmaceutical compositions containing them
UA26442C2 (uk) Фармкомпозиція для профілактики і лікуваhhя захворюваhь, пов'язаhих з порушеhhям обміhу речовиh
ES513974A0 (es) Procedimiento de preparacion de derivados del 3,4-difenil-5-metil pirazol.
IT8621874A0 (it) Procedimento di preparazione di additivi surbasati molto fluidi e a basicita' elevata, e composizione contenente i detti additivi.
ES512230A0 (es) "procedimiento de preparacion de derivados (7e,9z)-alcadienoles".
OA08630A (fr) Fraction immunogène active à l'égard des bilharzioses, sa préparation, compositions immunisantes la contenant.
ES509228A0 (es) "procedimiento para la preparacion de pirroles triciclicos".
GB1511196A (en) Creatinine pyrolidonecarboxylate
ES514224A0 (es) "procedimiento para la preparacion de 2,4-diamino-(3,5-dimetoxi-4-metoxietoxibenzil)-pirimidina".
GR852224B (pt)
ES516069A0 (es) "procedimiento para la preparacion de derivados de 1,2,3-tiadiazol-5-il-urea".
ES518725A0 (es) Procedimiento de preparacion de nuevos derivados del azabiciclo (3.2.0) heptano.
IT8420686A1 (it) "procedimenti per la preparazione di derivati del bis-idrossietilmercapto-1,10 - decano"/
CA1263380C (en) MYCAMINOSYLTYLONOLIDE COMPOUNDS SUBSTITUTED FOR C-23 AND PHARMACEUTICAL COMPOUNDS CONTAINING THEM
IT8223168A0 (it) Chinazoline piperidinil-sostituite aventi proprieta' farmacologiche, particolarmente proprieta'ipotensive, e procedimento per laloro preparazione.
ES512940A0 (es) "procedimiento para la preparacion de colorantes azo-estilbenicos".
DE3270466D1 (en) Pharmaceutical composition
NO913459D0 (no) Fremgangsmaate for fremstilling av 2',3'-dideoksy-2',3'-didehydronukleosider.